Search
Close this search box.

Patients

Smiling Arvinas scientific staff members working in Lab

Clinical Trials

Our clinical trials help to advance the understanding of innovative medicines and determine whether the new treatments being developed are safe and effective.

We know that the decision to participate in clinical trial research is not made lightly, and we sincerely thank all the patients and families who choose to partake. Your physician is the best person to help you decide if a clinical trial or any other treatment option is right for you.

The agents listed below are currently under investigation. Their safety and effectiveness have not yet been established.

Smiling Arvinas scientific staff members working in Lab
Arvinas scientific staff member preparing vials for testing
Display of different lab materials used in testing
Bavdegalutamide (ARV-110) is an investigational orally bioavailable PROTAC® protein degrader designed to selectively target and degrade the androgen receptor (AR). Bavdegalutamide is being developed as a potential treatment for men with metastatic castration-resistant prostate cancer (mCRPC).

Currently Recruiting:


If you’re interested in learning more about this trial, please speak with your doctor and visit the website www.clinicaltrials.gov

ARV-766 is an investigational orally bioavailable PROTAC® protein degrader designed to selectively target and degrade the androgen receptor (AR). ARV-766 is being developed as a potential treatment for men with metastatic castration-resistant prostate cancer (mCRPC).

Currently Recruiting:


If you’re interested in learning more about this trial, please speak with your doctor and visit the website www.clinicaltrials.gov

Search
Close this search box.

Arvinas

You are now leaving arvinas.com. Arvinas does not endorse or recommend the content in any third-party sites. Arvinas is not responsible and disclaims liability for the content, or for any viruses or similar harmful programs, that may be present on third-party pages or sites. Visits to a third-party website are at your own risk and subject to the terms and conditions and privacy policy of such site.

Skip to content